Financial News
Arena Pharmaceuticals (NQ: ARNA )
65.90
USD
-2.09
(-3.07%)
Official Closing Price
Updated: 4:59 PM EDT, Apr 16, 2021
Add to My Watchlist
Stories about Arena Pharmaceuticals
My Top 3 Favorite Clinical-Stage Biotech Stocks to Buy
November 17, 2018
From Motley Fool
11 NYSE- And NASDAQ-Listed Stocks With Cannabis Exposure
November 16, 2018
From Benzinga
64 Biggest Movers From Yesterday
November 15, 2018
From Benzinga
From CNBC.com News
Why Arena Pharmaceuticals, Smart & Final Stores, and Tilray Jumped Today
November 15, 2018
From Motley Fool
Noteworthy Thursday Option Activity: RESI, CRMT, ARNA
November 15, 2018
Tags
Stocks
From Market News Video
45 Stocks Moving In Thursday's Mid-Day Session
November 15, 2018
From Benzinga
This Biotech Stock Is Flying On A $1.2 Billion Licensing Deal
November 15, 2018
Mid-Day Market Update: Smart & Final Stores Rises Following Strong Q3 Earnings; Remark Holdings Shares Drop
November 15, 2018
From Benzinga
Here's Why Arena Pharmaceuticals Jumped as Much as 30.6% Today
November 15, 2018
From Motley Fool
From Benzinga
34 Stocks Moving In Thursday's Pre-Market Session
November 15, 2018
From Benzinga
Tags
companyNews
34 Stocks Moving In Friday's Pre-Market Session
November 09, 2018
From Benzinga
Arena Pharmaceuticals Shows Market Leadership With Jump To 83 RS Rating
November 07, 2018
The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Momenta Strikes Patent License Deal With AbbVie
November 06, 2018
From Benzinga
From CNBC.com News
Arena Pharmaceuticals Meets 80-Plus Relative Strength Rating Benchmark
November 04, 2018
The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs
November 04, 2018
From Benzinga
Interesting ARNA Put And Call Options For December 14th
November 01, 2018
Tags
Stocks
From Market News Video
Stock Upgrades: Arena Pharmaceuticals Shows Rising Relative Strength
October 11, 2018
The Daily Biotech Pulse: Affimed's Cancer Drug Placed On Clinical Hold, Celgene's Positive Scalp Psoriasis Trial
October 09, 2018
From Benzinga
Biotech Rises On Crohn's Disease Study For Cannabinoid Drug
September 25, 2018
Morning Call For Tuesday, Sept. 25
September 25, 2018
From Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.